Table 1 Participant characteristics
Median | Interquartile range | |
|---|---|---|
Personal characteristics | ||
Age | 52 | 46–59 |
Ethnicity | ||
White | 51 (63.8%) | |
Black | 8 (10.0%) | |
Mixed | 7 (8.8%) | |
Other/missing | 14 (17.5%) | |
Education | ||
High school | 16 (20%) | |
College (CEGEP), technical or vocational diploma | 20 (25%) | |
University level | 44 (55.0%) | |
Tobacco use | ||
Never | 43 (54%) | |
Past only | 31 (39%) | |
Current | 4 (5%) | |
Uncertain/Missing | 2 (2.6%) | |
Disease characteristics and laboratory values | ||
Duration of infection (years) | 13.8 | 8.7–23.0 |
CD4 T cell count (Cells/µL of blood) | 589 | 410–802 |
CD8 T cell count (Cells/µL of blood) | 750 | 560–1026 |
CD4:CD8 ratio | 0.8 | 0.5–1.1 |
HIV Viral load (copies/mL) | < 50 | Undetectable—< 50 |
Plasma I-FABP (pg/mL) | 965.5 | 659.6–1377 |
Plasma REG3α (pg/mL) | 4302.4 | 2921–6396 |
Plasma LPS (pg/mL) | 47.1 | 32.8–79 |
Plasma BDG (pg/mL) | 14.5 | 9.0–28 |
Brain health outcomes | ||
B-CAM (0–100, higher is better) | 61.76 | 52.94–72.06 |
PDQ (0–80, higher is worse) | 26.25 | 13.75–40.63 |